Skip to search
Skip to main content
Skip to first result
Maxine Singer - Profiles in Science
Contact
About
Maxine Singer
The Maxine Singer Papers
Home
The Story
Biographical Overview
Nucleic Acids, the Genetic Code, and Transposable Genetic Elements: A Life in Research
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
The Science Administrator as Advocate
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
Search Constraints
Start Over
You searched for:
Language
English
✖
Remove constraint Language: English
Format
Text
✖
Remove constraint Format: Text
Subject
DNA, Recombinant
✖
Remove constraint Subject: DNA, Recombinant
Exhibit Tags
regulation
✖
Remove constraint Exhibit Tags: regulation
« Previous |
1
-
50
of
53
|
Next »
Sort
by Date (newest to oldest)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
50
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
1.
Letter from Maxine Singer to William J. Gartland
Date:
4 October 1984
2.
Letter from Maxine Singer to London Ganning
Date:
13 August 1979
3.
Letter from London Ganning to Maxine Singer
Date:
24 July 1979
4.
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
Date:
28 June 1979
5.
Letter from Paul Berg to U.S. Senator Harrison Schmitt
Date:
5 January 1979
6.
Letter from Maxine Singer to Carolyn E. Kemp
Date:
27 November 1978
7.
Letter from Carolyn E. Kemp to Maxine Singer
Date:
31 October 1978
8.
Letter from Stanley N. Cohen to Maxine Singer
Date:
25 September 1978
9.
Letter from Roy Curtiss III to Donald S. Fredrickson
Date:
23 September 1978
10.
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
Date:
25 May 1978
11.
Memorandum from Maxine Singer to Donald S. Fredrickson
Date:
16 January 1978
12.
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
Date:
21 October 1977
13.
Letter from Maxine Singer to Donald S. Fredrickson
Date:
5 October 1977
14.
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
Date:
[ca. 9 June 1977]
15.
Letter from Maxine Singer to Lorill Brown-Rezanka
Date:
6 June 1977
16.
Letter from Roy Curtiss III to Maxine Singer
Date:
20 May 1977
17.
Letter from Roy Curtiss III to Donald S. Fredrickson
Date:
12 April 1977
18.
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
Date:
30 March 1977
19.
Testimony by David Baltimore for the Committee on Science and Technology
Date:
30 March 1977
20.
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
Date:
30 March 1977
21.
Letter from Maxine Singer to Milton P. Gordon
Date:
22 March 1977
22.
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
Date:
[March 1977]
23.
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
Date:
7 February 1977
24.
Testimony of Maxine Singer before the California State Legislature
Date:
28 January 1977
25.
Letter from Maxine Singer to U.S. Representative Richard Ottinger
Date:
26 January 1977
26.
Letter from David S. Hogness to DeWitt Stetten, Jr
Date:
26 January 1977
27.
Letter from Maxine Singer to Robert L. Sinsheimer
Date:
7 January 1977
28.
Letter from Maxine Singer to Charles Warren
Date:
7 January 1977
29.
Letter from Paul Berg to Robert L. Sinsheimer
Date:
30 December 1976
30.
Letter from Charles Warren and Barry Keene to Maxine Singer
Date:
29 December 1976
31.
A Statement
Date:
20 December 1976
32.
Letter from Maxine Singer to Wallace P. Rowe
Date:
24 August 1976
33.
Letter from Wallace P. Rowe to Maxine Singer
Date:
11 August 1976
34.
Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
June 1975
35.
Letter from David Baltimore to Fred C. Ikle
Date:
22 May 1975
36.
Letter from Maxine Singer to Willard Gaylin
Date:
30 April 1975
37.
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
Date:
[29 April 1975]
38.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[29 April 1975]
39.
Appendix F: Cloned Eukaryotic DNA
Date:
[29 April 1975]
40.
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
Date:
[29 April 1975]
41.
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
Date:
[29 April 1975]
42.
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
Date:
17 April 1975
43.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[15 April 1975]
44.
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
Date:
9 April 1975
45.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[Spring 1975]
46.
Appendix H: Provisional Statement of the Conference Proceedings
Date:
[27 February 1975]
47.
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
Date:
[25 February 1975]
48.
Appendix F: Cloned Eukaryotic DNA
Date:
[25 February 1975]
49.
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
Date:
24 February 1975
50.
Appendix C: Program of the International Conference on Recombinant DNA Molecules
Date:
[23 February 1975]
« Previous
Next »
1
2